Acute Myeloid Leukemia with Myelodysplasia-Related Changes
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutational analysis further demonstrated that TP53 mutations are associated with complex karyotype AML, whereas ASXL1 and U2AF1 mutations are associated with AML with myelodysplasia-related changes.
|
25412851 |
2015 |
Adenocarcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Our systematic analysis of proteins and glycoproteins demonstrates changes of protein and glycoprotein relative abundance in SqCC (TP53, U2AF1, and RXR) and in ADC (SMARCA4, NOTCH1, PTEN, and MST1).
|
28814946 |
2017 |
Adenocarcinoma of lung (disorder)
|
0.130 |
GeneticVariation
|
disease |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Adenocarcinoma of lung (disorder)
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Finally, we show that lung adenocarcinoma cell lines bearing U2AF1 mutations do not require the mutant protein for growth in vitro or in vivo.
|
27776121 |
2016 |
Adenocarcinoma of lung (disorder)
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Taken together, our results suggest a mechanistic interaction between mutant U2AF1 and ROS1 in LUAD.
|
31836708 |
2019 |
Adenocarcinoma of lung (disorder)
|
0.130 |
Biomarker
|
disease |
BEFREE |
Using RNA-Seq data from 182 lung adenocarcinomas and 167 acute myeloid leukemias (AML), in which U2AF1 is somatically mutated in 3-4% of cases, we identified 131 and 369 splicing alterations, respectively, that were significantly associated with U2AF1 mutation.
|
24498085 |
2014 |
Adenocarcinoma of pancreas
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
Adult Langerhans Cell Histiocytosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
|
29649018 |
2018 |
Adult Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.
|
23861105 |
2013 |
Adult Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians.
|
28938223 |
2017 |
Adult Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
|
23029227 |
2012 |
Ataxia Telangiectasia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we report a chain of events triggered by multiple splicing factor mutations, especially high-risk alleles in SRSF2 and U2AF1, including elevated R-loops, replication stress, and activation of the ataxia telangiectasia and Rad3-related protein (ATR)-Chk1 pathway.
|
29395063 |
2018 |
Borderline mucinous tumour of ovary
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In solid tumors, we found SF3B1 mutations in gastric and prostate cancers, and U2AF1 mutation in a borderline mucinous tumor of ovary, but the overall incidences of the hotspot mutation regions were very low (0.2%).
|
23280334 |
2013 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis.
|
31605415 |
2020 |
Carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have asked how the common S34F mutation in the splicing factor U2AF1 regulates alternative splicing in lung cancer, and why wild-type U2AF1 is retained in cancers with this mutation.
|
27776121 |
2016 |
Childhood Acute Myeloid Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We investigated possible alteration of the SETBP1, splicing factor 3B subunit 1 (SF3B1), U2 small nuclear RNA auxiliary factor 1 (U2AF1), and serine/arginine-rich splicing factor 2 (SRSF2) genes in childhood AML.
|
25553291 |
2015 |
Childhood Langerhans Cell Histiocytosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
|
29649018 |
2018 |
Childhood Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
|
23029227 |
2012 |
Childhood Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians.
|
28938223 |
2017 |
Childhood Myelodysplastic Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.
|
23861105 |
2013 |
Chronic Lymphocytic Leukemia
|
0.310 |
CausalMutation
|
disease |
CGI |
|
|
|
Chronic Lymphocytic Leukemia
|
0.310 |
Biomarker
|
disease |
BEFREE |
U2AF1 is frequently mutated in myeloid hematopoietic malignancies, especially in myelodysplastic syndrome (MDS), and SF3B1 is frequently mutated in both MDS and chronic lymphocytic leukemia (CLL).
|
22200771 |
2011 |
Complete Trisomy 21 Syndrome
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
As U2AF1 associates with a number of different factors during mRNA splicing, overexpression in trisomy 21 individuals could contribute to some Down syndrome phenotypes by interfering with the splicing process.
|
8660980 |
1996 |
Complete Trisomy 21 Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
It establishes definitely the contribution of the Abcg1-U2af1 orthologous region to the DS etiology and suggests new modulatory pathways for learning and memory.
|
19783846 |
2009 |
Congenital chromosomal disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We infer that U2AF1 S34 mutations characterize a distinct subgroup of MDS: younger age of onset and differential associations with particular cytogenetic aberrations depending on specific mutations [S34Y to +8; S34F to +8 and del(20q)].
|
28938223 |
2017 |